ID

12470

Descripción

The purpose of this trial is to evaluate the safety and indicators of efficacy of up to 4 doses of orally administered dabigatran etexilate, administered twice daily, compared to placebo when given in addition to dual antiplatelet treatment in patients with an index event (MI) at high risk for new ischaemic cardiovascular events. https://www.clinicaltrials.gov/ct2/show/NCT00621855

Link

https://www.clinicaltrials.gov/ct2/show/NCT00621855

Palabras clave

Versiones (2)
  1. 28/7/15 28/7/15 -
  2. 21/11/15 21/11/15 -
Subido en

21 de noviembre de 2015

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility RE-DEEM Acute Coronary Syndrome NCT00621855

Inglés

Eligibility criteria

1 formularios  
  1. StudyEvent: ODM
    1. Eligibility criteria
Inclusion criteria
Descripción

Inclusion criteria

Patients with acute coronary syndromes
Descripción

Patients with acute coronary syndromes

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0948089
with at least one additional risk factor for cardiovascular complications
Descripción

with at least one additional risk factor for cardiovascular complications

Tipo de datos

boolean

Alias
UMLS CUI-1
C0741920
Exclusion criteria
Descripción

Exclusion criteria

Long term treatment with any other oral anticoagulant
Descripción

Long term treatment with any other oral anticoagulant

Tipo de datos

boolean

Alias
UMLS CUI-1
C0354604
Severe/disabling stroke within last 6 months
Descripción

Severe/disabling stroke within last 6 months

Tipo de datos

boolean

Alias
UMLS CUI-1
C0038454
Conditions associated with increased bleeding risk
Descripción

Conditions associated with increased bleeding risk

Tipo de datos

boolean

Alias
UMLS CUI-1
C3251812
Anaemia
Descripción

Anaemia

Tipo de datos

boolean

Alias
UMLS CUI-1
C0002871
Thrombocytopenia
Descripción

Thrombocytopenia

Tipo de datos

boolean

Alias
UMLS CUI-1
C0040034
Severe renal impairment
Descripción

Severe renal impairment

Tipo de datos

boolean

Alias
UMLS CUI-1
C0035078
Liver disease
Descripción

Liver disease

Tipo de datos

boolean

Alias
UMLS CUI-1
C0085605
Positive pregnancy test
Descripción

Positive pregnancy test

Tipo de datos

boolean

Alias
UMLS CUI-1
C0549206
Volver a la parte superior de la página

Similar models

Eligibility criteria

1 formularios
  1. StudyEvent: ODM
    1. Eligibility criteria
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Inclusion criteria
Acute coronary syndrome
Item
Patients with acute coronary syndromes
boolean
C0948089 (UMLS CUI [1])
Cardiac risk factor
Item
with at least one additional risk factor for cardiovascular complications
boolean
C0741920 (UMLS CUI-1)
Item Group
Exclusion criteria
Oral Anticoagulants
Item
Long term treatment with any other oral anticoagulant
boolean
C0354604 (UMLS CUI-1)
Stroke
Item
Severe/disabling stroke within last 6 months
boolean
C0038454 (UMLS CUI-1)
Bleeding risk
Item
Conditions associated with increased bleeding risk
boolean
C3251812 (UMLS CUI-1)
Anaemia
Item
Anaemia
boolean
C0002871 (UMLS CUI-1)
Thrombocytopenia
Item
Thrombocytopenia
boolean
C0040034 (UMLS CUI-1)
Kidney failure
Item
Severe renal impairment
boolean
C0035078 (UMLS CUI-1)
Liver failure
Item
Liver disease
boolean
C0085605 (UMLS CUI-1)
Pregnancy
Item
Positive pregnancy test
boolean
C0549206 (UMLS CUI-1)
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial